Veracyte VCYT 深 沪
等待开盘 08-25 09:30:00 美东时间
41.105
-1.205
-2.85%
华盛通- 最 高42.067
- 今 开42.00
- 成交量 54.82万股
- 最 低 41.02
- 昨 收 42.31
- 总市值 33.04亿
- 52周最高 60.91
- 市盈率 静 49.91
- 换手率 0.68%
- 52周最低 29.375
- 委 比 -47.37%
- 总股本 8039.07万
- 历史最高 86.03
- 量 比 0.54
- 振 幅 2.47%
- 历史最低 4.21
- 每 手 1
- 风险率 8.10%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Top 3 Health Care Stocks That Could Blast Off This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give...
08-19 18:30
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
美股大行评级 | 最高400美元！亚马逊绩后获11家大行上调目标价；苹果绩后评级分歧大！3家上调，3家下调；德康医疗、万事达、神经分泌生物科学获多家大行上调目标价
今日重点评级关注：TD Cowen：维持加拿大鹅"买入"评级，目标价从13美元升至18美元；瑞银：维持吉登运动服"买入"评级，目标价从110美元升至111美元
08-03 11:38
财报速睇 | Veracyte 2026财年Q2营收1.50亿美元，同比增长15.5%；归母净利润0.25亿美元，扭亏为盈
华盛资讯8月1日讯，Veracyte公布2026财年Q2业绩，公司Q2营收1.50亿美元，同比增长15.5%，归母净利润0.25亿美元，扭亏为盈。
08-01 06:21
Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining around 300 points on Friday. Shares of Apple Inc (NASDAQ:AAPL) fell sharply in pre-market trading after the company posted results for the third quarter. Apple posted fiscal third-quarter revenue of $109.42 billion, bea...
07-31 20:03
Needham Maintains Buy on Veracyte, Raises Price Target to $69
Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $57 to $69.
07-31 17:46
美股夜盘 | AXT Inc涨22.99%，科休半导体涨18.99%
AXT Inc涨22.99%；科休半导体涨18.99%；Ryan Specialty Holdings, Inc. Class A涨10.80%
07-31 10:01
美股夜盘 | AXT Inc涨26.44%，科休半导体涨17.67%
AXT Inc涨26.44%；科休半导体涨17.67%；Ryan Specialty Holdings, Inc. Class A涨10.80%
07-31 09:01
Veracyte to Participate in Upcoming Investor Conferences
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced its participation in two upcoming investor conferences: the Canaccord Genuity 46th Annual Growth Conference in Boston on August 11 at 10:30 a.m. ET, and the Morgan Stanley 24th Annual Global Healthcare Conference in New York on September 15 at 5:35 p.m. ET. Live audio webcasts of the presentations will be available on Veracyte’s website at http://investor.veracyte.com/...
07-28 20:05
美股大行评级 | 潜在涨幅284.62%！Annexon获Needham上调目标价至25美元；多家大行上调美国银行目标价
今日重点评级关注：Needham：维持Annexon"买入"评级，目标价从11美元升至25美元；Benchmark：维持Prenetics Global"买入"评级，目标价从30美元升至40美元
07-16 18:55
